A:

Xuewen Song1,2, Feng Xue1, Lingling Chen1

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.

Advances in therapy
|June 4, 2025
PubMed
概括

这项研究揭示了中国的非最佳血友病A管理,预防的使用率低,成本高. 提高认识和治疗准入对于改善患者的治疗结果至关重要.